Major Depressive Disorder: Validated Treatments and Future Challenges

Source: World Journal of Clinical Cases. 9(31) (pp 9350-9367), 2021.

Date of Publication: 06 Nov 2021.

Author: Karrouri R.; Hammani Z.; Otheman Y.; Benjelloun R.

Abstract: Depression is a prevalent psychiatric disorder that often leads to poor
quality of life and impaired functioning. Treatment during the acute phase of a major depressive episode aims to help the patient reach a remission state and eventually return to their baseline level of functioning. Pharmacotherapy, especially selective serotonin reuptake inhibitors antidepressants, remains the most frequent option for treating depression during the acute phase, while other promising pharmacological options are still competing for the attention of practitioners. Depression focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses. Electroconvulsive therapy is the most effective somatic therapy for depression in some specific situations; meanwhile, other methods have
limits, and their specific indications are still being studied. Combining medications, psychotherapy, and somatic therapies remains the most effective way to manage resistant forms of depression.